Skip to search formSkip to main contentSkip to account menu

Clarithromycin

Known as: CLARITH, Clarithromycina, Clarithromycin [Chemical/Ingredient] 
A semisynthetic 14-membered ring macrolide antibiotic. Clarithromycin binds to the 50S ribosomal subunit and inhibits RNA-dependent protein synthesis… 
National Institutes of Health

Related topics

Related topics

42 relations

Narrower (2)

14-hydroxyclarithromycinBiaxin
24 HR Clarithromycin 500 MG Extended Release Oral Tablet6-O-methylerythromycin AAcute intermittent porphyriaAstemizole

Broader (3)

Anti-Bacterial AgentsCytochrome P-450 CYP3A InhibitorsMacrolide Antibiotics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Ten‐day sequential versus triple therapy for Helicobacter pylori eradication: A prospective, open‐label, randomized trial
Increased resistance of Helicobacter pylori to antibiotics has increased the need to develop new first‐line treatments for H… 
Review
2009
Review
2009
Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin‐based therapy in Taiwan
Background and Aim:  Clarithromycin‐based triple therapy has been commonly applied as the first‐line therapy for Helicobacter… 
Highly Cited
2007
Highly Cited
2007
Comparison of 7-day and 14-day Proton Pump Inhibitor-Containing Triple Therapy for Helicobacter pylori Eradication: Neither Treatment Duration Provides Acceptable Eradication Rate in Korea
Review
2005
Review
2005
Detection of reactive oxygen species in the skin of live mice and rats exposed to UVA light: a research review on chemiluminescence and trials for UVA protection
The harmful effects of ultraviolet (UV) exposure on the skin are associated with the generation of reactive oxygen species (ROS… 
2004
2004
Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998-2001 U S Surveillance Study.
Highly Cited
2001
Highly Cited
2001
A triple therapy regimen after failed Helicobacter pylori treatments
: Following standard triple therapy, up to 20% of patients require further Helicobacter pylori eradication treatment. Data… 
Highly Cited
1999
Highly Cited
1999
Quadruple Therapy Is Effective for Eradicating Helicobacter pylori After Failure of Triple Proton‐Pump Inhibitor–Based Therapy: A Detailed, Prospective Analysis of 21 Consecutive Cases
Background. Data regarding the effectiveness of second‐line treatment of Helicobacter pylori infection are limited, especially if… 
Highly Cited
1997
Highly Cited
1997
One‐week low‐dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers
Aim: To test the hypothesis that 1‐week low‐dose triple therapy for H. pylori is sufficient for relief from dyspeptic symptoms… 
1997
1997
DNA adducts of heterocyclic amines: formation, removal and inhibition by dietary components.
Highly Cited
1995
Highly Cited
1995
Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)